Related Experiment Video
Updated: Jul 13, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Motor cortex stimulation for Parkinson's disease.
1Neurochirurgia Funzionale e Spinale, Università Cattolica, Roma, Italy. bcioni@rm.unicatt.it
Acta Neurochirurgica. Supplement
|August 19, 2007
Summary
Motor cortex stimulation (MCS) shows potential for managing Parkinson disease (PD) symptoms, including dyskinesias and motor fluctuations. While variable, MCS offers a possible alternative to deep brain stimulation with observed improvements in motor function and quality of life.
Area of Science:
- Neurosurgery
- Neurology
- Medical Devices
Background:
- Early studies by Canavero and Paolotti suggested motor cortex stimulation (MCS) benefits Parkinson disease (PD) patients.
- MCS was proposed as a potentially cost-effective alternative to deep brain stimulation (DBS).
Purpose of the Study:
- To evaluate the efficacy and safety of chronic epidural motor cortex stimulation (MCS) for advanced Parkinson disease (PD).
- To assess the modulation of various PD symptoms and impact on quality of life.
Main Methods:
- An Italian Multicenter Study involving 29 Parkinson disease patients.
- Chronic epidural motor cortex stimulation (MCS) was applied, with outcomes assessed using UPDRS-III and PDQL scales.
Main Results:
- MCS modulated various PD symptoms, with variable and unpredictable improvement.
- Significant improvements were noted in L-Dopa induced dyskinesias, painful dystonia, and motor fluctuations.
- UPDRS-III scores improved by 30% at 3 months and 22% at 12 months; PDQL scores decreased by 26% at 12 months.
- No complications or adverse events were reported.
Conclusions:
- Preliminary data suggest MCS can modulate PD symptoms, improving motor function and quality of life.
- Further research is needed to determine optimal electrode placement, stimulation parameters, and patient selection criteria.
- The precise mechanisms underlying MCS efficacy in PD remain hypothetical.
More Related Videos
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:20Motor Unit Stimulation
When the neuron of a motor unit fires an action potential, it triggers a series of events, leading to a twitch contraction in the muscle fibers. The process of excitation-contraction coupling is crucial in relaying the action potential to the muscle fibers.
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...